Sponsor Dossier
CSL Behring
Sponsor Dossier for CSL Behring. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: “TBSF”
- Brand: AFSTYLA
- Brand: ALBUMEX
- Brand: ALBUNATE
- Brand: ALBUREX
- Brand: ALEVIATE
- Brand: ANDEMBRY
- Brand: BERINERT
- Device (sponsor): Medication transfer set
- Device (sponsor): Medication transfer set
- Device (sponsor): Medication transfer set
- Device (sponsor): Medicine administration kit, percutaneous, medicated, single-use
- Device (sponsor): Medication transfer set
- Device (sponsor): Medication transfer set
- Device (sponsor): Medicine administration kit, percutaneous, medicated, single-use
- Device (sponsor): Basic intravenous administration set, invasive
- Device (sponsor): Medicine administration kit, percutaneous, medicated, single-use
About
CSL Behring is an Australian Private Company with ABN 48 160 734 761, registered in Victoria. The entity is currently active.
Portfolio
CSL Behring has 22 brands on the ARTG, of which 19 are indexable and 16 carry a Product Information document. 1 brand is PBS-listed, 1 has a PBAC outcome on record, and 5 have an AusPAR on record. Notable brands include “TBSF”, AFSTYLA, ALBUMEX, ALBUNATE, ALBUREX, ALEVIATE, ANDEMBRY, BERINERT, BERIPLEX, BIOSTATE, CSL, HEMGENIX.
Therapeutic focus
— Haematology: 15 brands — Immunology: 5 brands — Respiratory: 1 brand — Rare Disease: 1 brand
PBS footprint
1 brand is PBS-listed, with the latest PBS schedule date 2026-10-01.
Regulatory activity
The latest PBAC outcome is 2024-11-01, across 1 brand with a PBAC outcome on record. The latest AusPAR is 2025-06-23, across 5 brands with an AusPAR on record.